D. Renmans

发表

Adjuvant-Enhanced mRNA Vaccines.

C. Heirman, K. Thielemans, K. Breckpot, 2017, Methods in molecular biology.

Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells

V. Flamand, C. Heirman, K. Thielemans, 2015, Cancer Immunology Research.

Non-invasive assessment of murine PD-L1 levels in syngeneic tumor models by nuclear imaging with nanobody tracers

Marleen Keyaerts, Nick Devoogdt, David Escors, 2017, Oncotarget.

Immune checkpoint blockade combined with IL‐6 and TGF‐β inhibition improves the therapeutic outcome of mRNA‐based immunotherapy

J. Aerts, C. Heirman, K. Thielemans, 2018, International journal of cancer.

The ReNAissanCe of mRNA-based cancer therapy

C. Heirman, K. Thielemans, K. Breckpot, 2015, Expert review of vaccines.

Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model

B. Neyns, S. Niclou, J. Aerts, 2015, Oncoimmunology.

Intralymphatic mRNA vaccine induces CD8 T-cell responses that inhibit the growth of mucosally located tumours

J. Aerts, C. Heirman, K. Thielemans, 2016, Scientific Reports.

Targeting the tumor microenvironment to enhance antitumor immune responses

C. Heirman, K. Thielemans, C. Goyvaerts, 2014, Oncotarget.

STAT3 modulates β-cell cycling in injured mouse pancreas and protects against DNA damage

H. Heimberg, M. Van de Casteele, W. Staels, 2016, Cell Death and Disease.